ARCA To Collaborate With Medtronic

ARCA biopharma Inc. (Nasdaq: ABIO) will collaborate with Medtronic Inc. (NYSE: MDT) to conducta Phase 2b/3 clinical trial of its atrial fibrillation prevention drug Gencaro. Shares of ARCA leaped 93 cents to close at $2.90 while Medtronic stock edged up 3 cents to close at $46.06.

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here